Capturing the human-bacterial relationship to address the seemingly impossible question - will this drug work [for me?]
BioCorteX has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
BioCorteX's investors include Sofinnova Partners, Ride Home Fund, Hoxton Ventures.
BioCorteX is headquartered in London, United Kingdom.
Capturing the human-bacterial relationship to address the seemingly impossible question - will this drug work [for me?]
BioCorteX is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioCorteX — Funding & Investors." VCBacked, March 28, 2023, https://www.vcbacked.co/company/biocortex. Accessed August 1, 2026.
VCBacked. (2023). BioCorteX — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/biocortex
{{cite web |title=BioCorteX — Funding & Investors |url=https://www.vcbacked.co/company/biocortex |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated